PULMONARY DRUG DELIVERY SYSTEMS MARKET ANALYSIS

Regional Analysis

Global Pulmonary Drug Delivery Systems Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global pulmonary drug delivery systems market over the forecast period. This is attributed to the increasing product launch  by market players. For instance, in October 2022, Aptar Digital Health, part of Aptar Pharma, a global leader in drug delivery and active material science solutions and services,  announced a strategic partnership with the Chiesi Group, the international research-focused biopharmaceutical and healthcare group, to bring to market a disease management platform for asthma and chronic obstructive pulmonary disease (COPD)

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa